Methods for using double-mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
View Patent ↗A method and kit for synthesizing a nucleic acid molecule comprising at least one non-canonical nucleoside triphosphate using a double-mutant polymerase having a reduced discrimination between canonical and non-canonical substrates is disclosed. The method comprises incubating a template nucleic acid in a reaction mixture comprising the mutant nucleic acid polymerase and the appropriate canonical and non-canonical nucleoside triphosphates which are desired substrates for the mutant nucleic acid polymerase. The present invention is also a method of determining the sequence of a nucleic acid molecule using the mutant polymerase to create a nucleic acid molecule comprising at least one non-canonical nucleoside triphosphate.
1. A method for synthesizing a nucleic acid molecule comprising at least one non-canonical nucleotide, comprising the steps of:
a) incubating a template nucleic acid in a reaction mixture under nucleic acid synthesis conditions containing (i) a double-mutant nucleic acid polymerase, wherein said polymerase has a reduced discrimination between canonical and non-canonical nucleoside triphosphates and wherein the polymerase is a T7 RNA polymerase comprising the mutation Y639F/H784A, and (ii) at least one non-canonical nucleoside triphosphate, wherein said non-canonical nucleoside triphosphate is incorporated into the synthesized nucleic acid in place of only one canonical nucleoside triphosphate, and
b) obtaining the synthesis of a nucleic acid molecule comprising at least one non-canonical nucleotide.
2. The method of claim 1 wherein the template nucleic acid is RNA.
3. The method of claim 1 wherein a nucleic acid molecule comprising at least one non-canonical nucleotide is synthesized by extension of a primer molecule, at least part of which is sufficiently complementary to a portion of the template to hybridize therewith.
4. The method of claim 1 wherein a nucleic acid molecule comprising at least one non-canonical nucleotide is synthesized de novo without using a primer molecule.
5. The method of claim 1 wherein the non-canonical nucleoside triphosphate is a 2′-fluoro-nucleoside triphosphate.
6. The method of claim 1 wherein the synthesized nucleic acid molecule is selected from the group consisting of a ribozyme and a nucleic acid molecule, wherein the molecule is used for gene therapy, in a vaccine, in an antiviral composition, in an antimicrobial composition, in an antisense composition for regulating gene expression, in a composition for hybridization to a complementary nucleic acid, or as a probe for detection of a complementary nucleic acid.
7. The method of claim 1 wherein the synthesized nucleic acid molecule is single-stranded.
8. The method of claim 1 , wherein a dinucleotide or trinucleotide for initiation of de novo nucleic acid synthesis is added to the reaction mixture.
9. The method of claim 8 , wherein the dinucleotide or trinucleotide in the reaction mixture is modified to contain a radioactive or non-radioactive label.
10. The method of claim 1 wherein the nucleic acid synthesis is part of or coupled to a method for nucleic acid amplification.